Abstract

N
This super-resolution microscopy method 4 produces high-resolution images (Fig. 1A) where assembly platforms made of Gag-i(mEOS2) are distinguishable as areas enriched in Gag proteins. Using that type of image, we can monitor the mean number of assembling sites occurring after 18 to 24 h of viral protein expression. On average we observed between 100 and 250 assembly platforms per cell. Since we are performing time lapse experiments, we can also determine the mean time of existence of these assembly platforms inside the cell. We find it in between 6 and 15 min, which corresponds to what Ivanchenko et al. 2 and Jouvenet et al. 3 found in human adherent HeLa cells expressing GFP-tagged Gag. Interestingly, as an advantage of the method, we can identify and characterize the final step of the process by observing some VLPs released in the extracellular medium. These VLPs are ∼100–140 nm in diameter and do not exhibit any dynamic or evolution in time, which is a signature of an achieved particle.

Spt-PALM 4 also allows to study the time-resolved evolution of the assembly, molecule after molecule at the nanoscale level (∼50 nm), that is, with a resolution higher than the virus assembly platform size of 110–140 nm in diameter. The total number of localizations for the entire acquisition time is in the order of 107 per cell, leading to ∼105 to 106 analyzable trajectories. By tuning acquisition frequency, we can select mainly slow diffusing proteins (D<2 μm2·s−1), that is, membrane-associated proteins. Thus, by reconstructing images of the different Gag trajectories (Fig. 1B), we can identify Gag proteins getting trapped into the assembly sites as well as others freely diffusing at the cell plasma membrane of Jurkat T cells (transposable to primary CD4 T lymphocytes). We are currently analyzing these trajectories using newly developed tools and big data facilities to give access to new molecular details about HIV-1 Gag assembly dynamic in its natural host cells and to improve our knowledge about the late stages of HIV-1 replication in CD4 T lymphocytes.
Footnotes
Author Disclosure Statement
No competing financial interests exist.
